跳至主要内容
临床试验/EUCTR2010-019981-94-FI
EUCTR2010-019981-94-FI进行中(未招募)不适用

Attention Deficit Hyperactivity Disorder (ADHD) and opioid maintenance therapy.A randomized, placebo-controlled study of the efficacy of atomoxetine for treating adult ADHD in patients receiving opioid maintenance therapy

HUS/ Neuropsykiatrian poliklinikka0 个研究点目标入组 30 人开始时间: 2010年7月23日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Study inclusion requires patients to meet DSM-IV criteria for ADHD in childhood and adulthood as well as opioid dependence. Patients must have been committed to opioid maintenance therapy for at least six months prior to study entry.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria are an unstable medical or psychiatric condition, pregnancy and nursing or a known sensitivity to atomoxetine.

研究者

发起方
HUS/ Neuropsykiatrian poliklinikka

相似试验

Attention Deficit Hyperactivity Disorder (ADHD) and... | 临床试验